Abstract
The aim of this study was to investigate the effect of chronic hypoxia on the development and progression of atherosclerosis in apolipoprotein E-knockout (apoE-KO) mice. Male and female apoE-KO mice (6 weeks old) and age- and sex-matched wild-type mice were kept under hypoxic conditions (10.0±0.5% O2) in a gas chamber or in room air for 3 weeks. Aortic atherosclerotic plaque was not observed in wild-type mice under normoxic or hypoxic conditions. In the apoE-KO mice, however, hypoxia induced proliferation of smooth muscle cells and plaque formation in the aorta, which were not observed under normoxic conditions. Although sexual dimorphism of the response to hypoxia was not observed, these hypoxia-induced atherogenic changes were accompanied by a significant increase of plasma low density lipoprotein (LDL) cholesterol and NADPH-dependent vascular superoxide (O2−) production. Furthermore, matrix metalloproteinase (MMP)-9 was activated in the aorta of apoE-KO mice. In conclusion, chronic hypoxia accelerated the development of atherosclerosis in apoE-KO mice, along with increased O2− production and activated MMP-9 in the aorta.
Similar content being viewed by others
Article PDF
References
Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D : Probucol inhibits oxidative modification of low-density lipoprotein. J Clin Invest 1986; 77: 641–644.
Barry-Lane PA, Patterson C, van der Merwe M, et al: p47phox is required for atherosclerotic lesion progression in ApoE−/− mice. J Clin Invest 2001; 108: 1513–1522.
Williams RJ, Motteram JM, Sharp CH, Gallagher PJ : Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 1992; 94: 153–159.
Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS : Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. J Clin Invest 1996; 98: 2572–2579.
Yasunari K, Maeda K, Nakamura M, Yoshikawa J : Carvedilol inhibits pressure-induced increase in oxidative stress in coronary smooth muscle cells. Hypertens Res 2002; 25: 419–425.
Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT : Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhanced by angiotensin II. Proc Natl Acad Sci U S A 1997; 94: 14483–14488.
Yin CJ, Xu JW, Takahashi K, Nara Y, Yamori Y : Tea polyphenols regulate nicotinamide adenine dinucleotide phosphate oxidase subunit expression and ameliorate angiotensin II-induced hyperpermeability in endothelial cells. Hypertens Res 2003; 26: 823–828.
Pinsky DJ, Oz MC, Koga S, et al: Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest 1994; 93: 2291–2297.
Griendling KK, Ushio-Fukai M : Redox control of vascular smooth muscle proliferation. J Lab Clin Med 1998; 132: 9–15.
Gonzalez W, Fontaine V, Pueyo ME, et al: Molecular plasticity of vascular wall during NG-nitro-L-arginine methyl ester-induced hypertension: modulation of proinflammatory signals. Hypertension 2000; 36: 103–109.
Galis ZS, Sukhova GK, Lark MW, Libby P : Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493–2503.
Damås JK, Wæhre T, Yndestad A, Gullestad L, Aukrust P : Atherosclerotic plaque stabilization—potential role for immunomodulatory therapy. Vasc Dis Prevent 2004; 1: 17–31.
Duranteau J, Chandel NS, Kulisz A, Shao Z, Schumacker PT : Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 1998; 273: 11619–11624.
Aoki M, Nata T, Morishita R, et al: Endothelial apoptosis induced by oxidative stress through activation of NF-κB. Antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 2001; 38: 48–55.
Chen L, Einbinder E, Zhang Q, Hasday J, Balke WC, Scharf SM : Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med 2005; 172: 915–920.
Martin JM, Carrizo SJ, Vicente E, Agusti AGN : Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046–1053.
Takai S, Jin D, Sakaguchi M, et al: Comparative effects of candesartan and amlodipine in a monkey atherosclerotic model. Hypertens Res 2004; 27: 517–522.
Miller FJ, Okuda N, Hayashi T, Mori T, et al: Nifedipine enhances the cardioprotective effect of an angiotensin-II receptor blocker in an experimental animal model of heart failure. Hypertens Res 2005; 28: 431–438.
Isoda K, Shiigai M, Ishigai N, et al: Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury. Circulation 2003; 108: 516–518.
Miller FJ, Cutterman DD, Rios DC, Heistad DD, Davidson BL : Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998; 82: 1298–1305.
Nakano D, Itoh C, Ishii F, et al: Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats. Biol Pharm Bull 2003; 26: 1701–1705.
Li Y, Zhu H, Kuppusamy P, Rouband V, Zweier JL, Trush MA : Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem 1998; 273: 2015–2023.
Skatchkov MP, Sperling D, Hink U, et al: Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. Biochem Biophys Res Commun 1999; 254: 319–324.
Hayashi T, Sohmiya K, Ukimura A, et al: Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart. Heart 2003; 89: 1236–1242.
Hayashi T, Nozawa M, Sohmiya K, et al: Efficacy of pancreatic transplantation on cardiovascular alterations in diabetic rats: an ultrastructural and immunohistochemical study. Transplant Proc 1998; 30: 335–338.
Budhiraja R, Tuder RM, Hassoun PM : Endothelial dysfunction in pulmonary hypertension. Circulation 2004; 109: 159–165.
Carmena R, Duriez P, Fruchart JC : Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004; 109 ( Suppl III): III-2–III-7.
Matsumoto K, Taniguchi T, Fujioka Y, Shimizu H, Ishikawa Y, Yokoyama M : Effects of hypoxia on cholesterol metabolism in human monocyte-derived macrophages. Life Sci 2000; 67: 2083–2091.
Wada Y, Sugiyama A, Yamamoto T, et al: Lipid accumulation in smooth muscle cells under LDL loading is independent of LDL receptor pathway and enhanced by hypoxic conditions. Arterioscler Thromb Vasc Biol 2002; 22: 1712–1719.
Sato H, Sato M, Kanai H, et al: Mitochondrial reactive oxygen species and c-Src play a critical role in hypoxic response in vascular smooth muscle cells. Cardiovasc Res 2005; 67: 714–722.
Schäfer M, Schäfer C, Ewald N, Piper HM, Noll TH : Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia. Circ Res 2003; 92: 1010–1015.
Cathcart MK : Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 23–28.
Kalinina N, Agrotis A, Tararak E, et al: Cytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2002; 22: 2037–2043.
Galis ZS, Khatri JJ : Matrix metalloproteinases in vascular remodeling and atherogenesis. The good, the bad, and the ugly. Circ Res 2002; 90: 251–262.
Galia ZS, Sukhova GK, Kranzhöfer R, Clark S, Libby P : Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A 1995; 92: 402–406.
Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM : Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 1995; 91: 2125–2131.
Lemaître V, O'Byrne TK, Borczuk AC, Okada Y, Tall AR, D'Armiento J : ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest 2001; 107: 1227–1234.
Potier M, Elliot SJ, Tack I, et al: Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol 2001; 12: 241–251.
Xu Y, Arenas IA, Armstrong SJ, Davidge ST : Estrogen modulation of left ventricular remodeling in the aged heart. Cardiovasc Res 2003; 57: 388–394.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakano, D., Hayashi, T., Tazawa, N. et al. Chronic Hypoxia Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Knockout Mice. Hypertens Res 28, 837–845 (2005). https://doi.org/10.1291/hypres.28.837
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.28.837
Keywords
This article is cited by
-
HIF1α activation in dendritic cells under sterile conditions promotes an anti-inflammatory phenotype through accumulation of intracellular lipids
Scientific Reports (2020)
-
Coronary Vessel Wall Imaging: State of the Art and Future Directions
Current Cardiovascular Imaging Reports (2019)
-
Low ambient oxygen prevents atherosclerosis
Journal of Molecular Medicine (2016)
-
Hypoxemia as a model for high altitude and cardiovascular risk reduction
Journal of Molecular Medicine (2016)
-
Potential Contributions of Intimal and Plaque Hypoxia to Atherosclerosis
Current Atherosclerosis Reports (2015)